Compagnie Lombard Odier SCmA’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $253K | Hold |
|
|||||
|
2025
Q2 | $236K | Hold |
|
|||||
|
2025
Q1 | $285K | Hold |
|
|||||
|
2024
Q4 | $321K | Hold |
|
|||||
|
2024
Q3 | $473K | Hold |
|
|||||
|
2024
Q2 | $473K | Sell |
|
|||||
|
2024
Q1 | $621K | Sell |
|
|||||
|
2023
Q4 | $606K | Hold |
|
|||||
|
2023
Q3 | $568K | Sell |
|
|||||
|
2023
Q2 | $1.28M | Hold |
|
|||||
|
2023
Q1 | $1.46M | Sell |
|
|||||
|
2022
Q4 | $1.36M | Hold |
|
|||||
|
2022
Q3 | $1.29M | Hold |
|
|||||
|
2022
Q2 | $1.11M | Hold |
|
|||||
|
2022
Q1 | $1.31M | Hold |
|
|||||
|
2021
Q4 | $1.19M | Hold |
|
|||||
|
2021
Q3 | $1.14M | Buy |
|
|||||
|
2021
Q2 | $598K | Sell |
|
|||||
|
2021
Q1 | $556K | Sell |
|
|||||
|
2020
Q4 | $652K | Buy |
|
|||||
|
2020
Q3 | $711K | Buy |
|
|||||
|
2020
Q2 | $617K | Sell |
|
|||||
|
2020
Q1 | $576K | Buy |
|
|||||
|
2019
Q4 | $300K | Sell |
|
|||||
|
2019
Q3 | $250K | Hold |
|
|||||
|
2019
Q2 | $282K | Sell |
|
|||||
|
2019
Q1 | $483K | Sell |
|
|||||
|
2018
Q4 | $552K | Buy |
|
|||||
|
2018
Q3 | $566K | Hold |
|
|||||
|
2018
Q2 | $483K | Sell |
|
|||||
|
2018
Q1 | $503K | Sell |
|
|||||
|
2017
Q4 | $1.12M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $27K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $98K | Hold |
|
|||||
|
2014
Q4 | $89K | Sell |
|
|||||
|
2014
Q3 | $254K | Sell |
|
|||||
|
2014
Q2 | $263K | Hold |
|
|||||
|
2014
Q1 | $280K | Buy |
|
|||||
|
2013
Q4 | $148K | Buy |
|